small molecule

RAYOS

PREDNISONE

Loss of exclusivityAugust 2027latest FDA-listed patent expiry
CompanyHORIZON THERAPEUTICS USA INC

Drug detail

Brand nameRAYOS
Active ingredientPREDNISONE
Strength1MG
Dosage formTABLET, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2012
Marketing statusDISCN

Listed patents

PatentExpiresType
9504699August 2027use U-1362

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

RAYOS patent cliff — loss of exclusivity August 2027 | CliffBio